Press release
Glioblastoma Multiforme Treatment Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Glioblastoma multiforme treatment drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are fuelling the market growth include the growing prevalence of glioblastoma multiforme, increasing R&D, and favourable regulatory scenarios, which are anticipated to boost the market growth. The presence of a strong pipeline is expected to act as a major driver for the glioblastoma multiforme (GBM) treatment market during the forecast period. The increasing incidence of brain tumors is expected to drive the growth of the global glioblastoma multiforme treatment market over the forecast period.The increasing approval for novel therapy and combination therapy is expected to drive the market in the coming years. For instance, in June 2019, the U.S. FDA approved Pfizer's Zirabev, a biosimilar for Avastin, for the treatment of recurrent glioblastoma, NSCLC, and colorectal cancer, among others. In January 2020, the company launched its product in the U.S.
The global glioblastoma multiforme treatment drugs market analysis includes some of the key market players such as Sanofi S.A., Eli Lilly and Company, AstraZeneca plc., Astellas Pharma Inc., and Johnson & Johnson (Janss en Pharmaceuticals), among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in November 2019, the U.S. FDA accepted Samsung's BLA application for its SB8 bevacizumab biosimilar candidate, which will increase the potential to launch products in the coming years.
To Request a Sample of our Report on Glioblastoma Multiforme Treatment Drugs Market: https://www.omrglobal.com/request-sample/glioblastoma-multiforme-treatment-drugs-market
Market Coverage
· The market number available for - 2021-2029
· Base year- 2021
· Forecast period- 2023-2029
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Bausch Health Companies Inc., Nestlé (Galderma), Leo Pharma Inc., Hovione FarmaCiencia SA, and Aclaris Therapeutics, among others.
Glioblastoma Multiforme Treatment Drugs Market by Segment
By Treatment
• Surgery
• Chemotherapy
• Radiation Therapy
• Others
By Drug Class
• Temozolomide
• Bevacizumab
• Lomustine
• Others
By End-Use
• Hospitals
• Clinics
• Ambulatory Surgical Centers
A full Report of Glioblastoma Multiforme Treatment Drugs Market is Available at: https://www.omrglobal.com/industry-reports/glioblastoma-multiforme-treatment-drugs-market
Glioblastoma Multiforme Treatment Drugs Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ed%99%95%ec%9e%a5%eb%90%a0-%ea%b2%83%ec%9c%bc%eb%a1%9c-%ec%98%88%ec%83%81%eb%90%98%eb%8a%94-%eb%8f%99%ec%b6%95-%ec%9e%a5%eb%b9%84-%ec%8b%9c%ec%9e%a5-%ea%b0%80%ec%b9%98/380346/
https://monblogapple.com/2023/03/03/le-marche-des-analyseurs-de-processus-devrait-augmenter-a-un-tcac-stable-au-cours-de-la-periode-de-prevision-2023-a-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%ef%bc%8c%e9%8a%b7%e5%94%ae%e7%b8%be%e6%95%88%e7%ae%a1%e7%90%86%e5%b8%82%e5%a0%b4%e5%b0%87%e5%8a%a0%e9%80%9f%e5%a2%9e%e9%95%b7/470772/
https://revistaeconomiasocial.com/2023/03/03/el-mercado-de-ensamblaje-de-cable-de-fibra-optica-monomodo-significara-un-fuerte-crecimiento-para-2023-2029/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d8%aa%d8%aa%d9%88%d8%b3%d8%b9-%d8%a7%d9%84%d9%82%d9%8a%d9%85%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d9%88/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioblastoma Multiforme Treatment Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 2963830 • Views: …
More Releases from Orion Market Research

Aviation Connectors Market By Application Analysis, Regional Outlook, Competitiv …
The global aviation connectors market was valued at approximately USD 5.6 billion in 2024 and is projected to reach around USD 11.42 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.14% from 2025 to 2034.
Aviation Connectors Market Overview
The aviation connectors market is experiencing robust growth, driven by the increasing demand for advanced avionics systems and the expansion of both commercial and military aircraft fleets.…

Industrial Wastewater Treatment Chemicals Market Development, Industry Trends, D …
The global industrial wastewater treatment chemicals market was valued at approximately USD 19.06 billion in 2024 and is projected to reach around USD 23.6 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033.
Industrial Wastewater Treatment Chemicals Market Overview
The global industrial wastewater treatment chemicals market is witnessing significant growth driven by increasing industrialization, stringent environmental regulations, and the growing need for sustainable water management. The…

Electronic Adhesives Market Development, Industry Trends, Demand and Growth Anal …
The global Electronic Adhesives Market was valued at approximately USD 5.11 billion in 2024 and is projected to reach USD 8.52 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5.6% between 2025 and 2033.
Electronic Adhesives Market Overview
The Electronic Adhesives Market is witnessing steady growth, driven by increased adoption of miniaturized electronics, EV components, and consumer gadgets requiring robust bonding, encapsulation, and thermal management. Key…

Automotive Interior Materials Market Size Future Scope, Demands and Projected In …
The global Automotive Interior Materials Market was valued at approximately USD 62.98 billion in 2024 and is projected to reach USD 91.20 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 4.2% during the period from 2025 to 2033.
Automotive Interior Materials Market Overview
The Automotive Interior Materials Market is poised for steady expansion, propelled by rising consumer demand for luxury, comfort, and lightweight vehicle interiors. With stringent…
More Releases for Glioblastoma
Key Trends Shaping the Future Glioblastoma Multiforme Market From 2025-2034: Adv …
Which drivers are expected to have the greatest impact on the over the glioblastoma multiforme market's growth?
The growing number of brain disorder cases is anticipated to boost the glioblastoma multiforme market in the coming years. A brain disorder is a condition that affects the brain's structure or function, leading to cognitive, emotional, or physical difficulties. The rise in brain disorder cases is attributed to factors such as an aging population,…
Glioblastoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Glioblastoma Pipeline Insight, 2024," report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioblastoma Pipeline Report
* DelveInsight's Glioblastoma pipeline report depicts…
Glioblastoma Multiforme Market Insights, Forecast to 2031
"Glioblastoma Multiforme Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Glioblastoma Multiforme market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Glioblastoma Multiforme industry, providing stakeholders with a nuanced perspective on market…
Beyond Bravery - Bill Fitzpatrick's Fight Against Glioblastoma
Bill Fitzpatrick Jr, a retired sales professional from GE, has recently ventured into the world of writing with his debut book. Inspired by his experiences during taking care of his wife, who had Glioblastoma, Bill felt the need to share his journey and provide support to other families navigating similar challenges. In this article, we will dive into Bill's background, his motivation for becoming an author, details about his latest…
Recurrent Glioblastoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Recurrent Glioblastoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Recurrent Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Recurrent Glioblastoma Pipeline Report
DelveInsight's Recurrent Glioblastoma…
Revolutionizing Glioblastoma Treatment Strategies: A Deep Dive into the Glioblas …
The Glioblastoma Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of Glioblastoma treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the Glioblastoma pipeline landscape and fostering the potential growth of Glioblastoma therapeutic advancements.
Key Takeaways from the Glioblastoma Pipeline Report
• DelveInsight's Glioblastoma pipeline report depicts a robust space with 195+ active players…